These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19427823)

  • 1. [Hypercholesterolemia: a therapeutic approach].
    Moráis López A; Lama More RA; Dalmau Serra J;
    An Pediatr (Barc); 2009 May; 70(5):488-96. PubMed ID: 19427823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering medications.
    Rodenburg J; Vissers MN; Daniels SR; Wiegman A; Kastelein JJ
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():171-80. PubMed ID: 16456497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children.
    Ose L
    Semin Vasc Med; 2004 Feb; 4(1):51-7. PubMed ID: 15199433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for the treatment of hypercholesterolemia].
    Hanefeld M
    Z Gesamte Inn Med; 1990 Aug; 45(15):457-60. PubMed ID: 2247995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum total cholesterol--an indicator for monitoring cholesterol lowering efforts: U.S. adults, 2005-2006.
    Schober SE; Carroll MD; Lacher DA; Hirsch R;
    NCHS Data Brief; 2007 Dec; (2):1-8. PubMed ID: 19389314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patient at risk: who should we be treating?
    Leitersdorf E
    Br J Clin Pract Suppl; 1994 Dec; (77):24-7. PubMed ID: 19496269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aorta and coronary angiographic follow-up of children with severe hypercholesterolemia treated with low-density lipoprotein apheresis.
    Stefanutti C; Vivenzio A; Di Giacomo S; Mazzarella B; Bosco G; Berni A
    Transfusion; 2009 Jul; 49(7):1461-70. PubMed ID: 19389031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of dyslipidaemias with fluvastatin.
    Peters TK
    Br J Clin Pract Suppl; 1994 Dec; (77):16-9. PubMed ID: 19514133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations for children with hypercholesterolemia].
    Girardet JP; Luc G; Rieu D; Bruckert E; Darmaun D; Farnier M; ;
    Arch Pediatr; 2011 Feb; 18(2):217-29. PubMed ID: 21145715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of hypercholesterolemia in children: needs and concerns].
    Capuano V; Rocco A; Lamaida N; Capuano E
    G Ital Cardiol (Rome); 2011 Nov; 12(11):707-16. PubMed ID: 22048445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary isoflavones on plasma cholesterol.
    Zdrenghea D; Pop D; Colcear D
    Rom J Intern Med; 2006; 44(4):353-63. PubMed ID: 18386612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Academy of Pediatrics. Committee on Nutrition. Cholesterol in childhood.
    American Academy of Pediatrics. Committee on Nutrition
    Pediatrics; 1998 Jan; 101(1 Pt 1):141-7. PubMed ID: 11345978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid control in diabetic patients in Extremadura (Spain)].
    Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
    Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent obesity: etiology, office evaluation, and treatment.
    Peebles R
    Adolesc Med State Art Rev; 2008 Dec; 19(3):380-405, vii. PubMed ID: 19227382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
    Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
    Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S
    J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.